Dark biotechnology, often referred to as "black biotechnology," encompasses the application of biotechnological processes to develop products or technologies with potentially harmful or controversial implications. Unlike its counterparts in white and red biotechnology, which focus on medical and industrial applications, dark biotechnology delves into areas that raise ethical concerns. This field includes activities such as bio-warfare research, bioterrorism, and the creation of biological weapons. The manipulation of living organisms for destructive purposes has sparked debates about the ethical boundaries and the need for stringent regulations to prevent the misuse of scientific advancements. The ethical considerations surrounding dark biotechnology highlight the importance of responsible research practices and global cooperation to mitigate the potential risks associated with these controversial applications.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States